ANTIBIOTIC USE AMONG PATIENTS WITH ACUTE EXACERBATION OF COPD IN PULMONARY DISEASES UNIVERSITY CLINICAL HOSPITAL FROM NORTH-EASTERN ROMANIA
Abstract
Aims: Acute exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) need sometimes hospitalizations and requires five to seven days of oral antibiotics, according to GOLD recommendations. The aim of our study was to find out the most common used antibiotics in patients with AECOPD admitted in a University Clinical Hospital of Pulmonary Diseases from North-Eastern Romania, from June 2014 to May 2019. Materials and methods: A descriptive cross-sectional, single-center, retrospective study, conducted among 460 admissions in hospital with J44.0 (COPD with lower airway acute infection) and J44.1 (COPD with acute, nonspecific exacerbation) diagnostics. Results: The majority (354; 77%) of admissions were for male; average age was 66 ± 9 years. The preferred antibiotic for first use was ceftriaxone (51%), but the patients were treated also with ciprofloxacin (13%), levofloxacin (12%), ceftazidime, amoxicillin + clavulanic acid or other antibiotics according to antibiograms, with a medium of 10 days treatment. Most of the patients received one antibiotic during hospitalization, 23.9% received two antibiotics and 7.6% of patients received 3 antibiotics. Hospitalization average length was 11 ± 5 days. Conclusions: Ceftriaxone was the preferred drug for acute COPD exacerbation treatment for hospitalized patients, while the average hospital length in our study was 11 days.
References
2. Bouquet J, Tabor DE, Silver JS, et al. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort. Respir Res 2020; 21, article 77.
3. World Health Organization. The top 10 causes of death. Dec 2020. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (accessed on 27/12/2022).
4. Eurostat. Statistics explained. Causes of death statistics. 2022 https://ec.europa.eu/eurostat/ statisticsex-plained/index.php?title=Causes_of_death_statistics #Main_causes of_death_by_country_in_2019 (last accessed on February 2022.
5. Global Initiative for Chronic Obstructive Lung Disease. 2024 report. https://goldcopd.org/2024-gold-report/(last accessed on May 2024)
6. Wedzicha JA, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: a European Res-piratory Society/American Thoracic Society guideline. Eur Respir J 2017; 49: 1600791.
7. Zhang J, Qun Y, Zhou C, et al. Characteristics, treatments, in-hospital and long-term outcomes among in patients with acute exacerbation of chronic obstructive pulmonary disease in China: sex differences in a large cohort study. BMC Pulmonary Medicine 2024; 24: 125 / doi: 10.1186/s12890-024-02948-4.
8. Ritchie AI, Brill SE, Vlies BH, et al. Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin a Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial. Am J Respir Crit Care Med 2020; 202(4): 549-557.
9. Roberts MH, Clerisme-Beatyet E, Kozma CM, et al. A retrospective analysis to identify predictors of COPD-related rehospitalization. BMC Pulmonary Medicine 2016; 16: 68.
10. Sanjay S, Aaron SD. Antibiotic Retreatment for Acute Exacerbations of Chronic Obstructive Pulmo-nary Disease. Am J Respir Crit Care Med. 2020; 202(4): 481-482.
11. Yan M, Saxena FE, Calzavara A, et al. Long-term macrolide therapy for chronic obstructive pulmonary disease: a population-based time series analysis. CMAJ Open. 2021; 9(2): E576-E584.
12. Mushlin AI, Black ER, Connolly CA, Buonaccorso KM, Eberly SW. The necessary length of hospital stay for chronic pulmonary disease. JAMA 1991; 266(1): 80-83.
13. Ko FWS, Chan KP, Ngai J, et al. Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations. Respirology 2020; 25: 259-266.
14. Li M, Cheng K, Ku K, Li J, Hu H, Ung COL. Factors influencing the length of hospital stay among patients with chronic obstructive pulmonary disease (COPD) in Macao population: a retrospective study of inpatient health record. Int J Chronic Obstr Pulm Dis 2021; 16: 1677-1685.
Additional Files
Published
Issue
Section
License
COPYRIGHT
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.
COPYRIGHT TRANSFER FORM FOR
REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /
THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI
We, the undersigned authors of the manuscript entitled
_____________________________________________________________________________________
_____________________________________________________________________________________
warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.
- we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
- the manuscript does not break the intellectual property rights of any other person.
- we have read the submitted version of the manuscript and we are fully responsible for the content.
Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):
- ______________________________/_________________________
- ______________________________/_________________________
- ______________________________/_________________________
N.B. All the authors must sign this form
